Omnicell Inc (OMCL)
30.18
-0.10
(-0.33%)
USD |
NASDAQ |
May 15, 15:31
Omnicell Enterprise Value: 1.437B for May 14, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 14, 2024 | 1.437B |
May 13, 2024 | 1.460B |
May 10, 2024 | 1.429B |
May 09, 2024 | 1.435B |
May 08, 2024 | 1.422B |
May 07, 2024 | 1.438B |
May 06, 2024 | 1.423B |
May 03, 2024 | 1.430B |
May 02, 2024 | 1.391B |
May 01, 2024 | 1.294B |
April 30, 2024 | 1.277B |
April 29, 2024 | 1.304B |
April 26, 2024 | 1.325B |
April 25, 2024 | 1.292B |
April 24, 2024 | 1.306B |
April 23, 2024 | 1.352B |
April 22, 2024 | 1.340B |
April 19, 2024 | 1.324B |
April 18, 2024 | 1.297B |
April 17, 2024 | 1.252B |
April 16, 2024 | 1.270B |
April 15, 2024 | 1.280B |
April 12, 2024 | 1.294B |
April 11, 2024 | 1.301B |
April 10, 2024 | 1.306B |
Date | Value |
---|---|
April 09, 2024 | 1.361B |
April 08, 2024 | 1.327B |
April 05, 2024 | 1.310B |
April 04, 2024 | 1.313B |
April 03, 2024 | 1.312B |
April 02, 2024 | 1.320B |
April 01, 2024 | 1.361B |
March 31, 2024 | 1.388B |
March 28, 2024 | 1.432B |
March 27, 2024 | 1.433B |
March 26, 2024 | 1.371B |
March 25, 2024 | 1.394B |
March 22, 2024 | 1.372B |
March 21, 2024 | 1.396B |
March 20, 2024 | 1.372B |
March 19, 2024 | 1.359B |
March 18, 2024 | 1.351B |
March 15, 2024 | 1.361B |
March 14, 2024 | 1.357B |
March 13, 2024 | 1.364B |
March 12, 2024 | 1.379B |
March 11, 2024 | 1.388B |
March 08, 2024 | 1.401B |
March 07, 2024 | 1.378B |
March 06, 2024 | 1.366B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
1.252B
Minimum
Apr 17 2024
8.103B
Maximum
Jan 03 2022
3.943B
Average
3.357B
Median
Enterprise Value Benchmarks
Teladoc Health Inc | 2.602B |
American Shared Hospital Services | 29.83M |
Novo Integrated Sciences Inc | 13.36M |
Astrana Health Inc | 1.669B |
Cryo-Cell International Inc | 84.03M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -15.68M |
Revenue (Quarterly) | 246.15M |
Total Expenses (Quarterly) | 268.00M |
EPS Diluted (Quarterly) | -0.34 |
Gross Profit Margin (Quarterly) | 37.63% |
Profit Margin (Quarterly) | -6.37% |
Earnings Yield | -1.52% |
Normalized Earnings Yield | -1.524 |